Log in to save to my catalogue

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5732162

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS

About this item

Full title

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2017-12, Vol.7 (1), p.17652-10, Article 17652

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Amyotrophic lateral sclerosis (ALS), the commonest adult-onset motor neuron disorder, is characterized by a survival span of only 2–5 years after onset. Relevant biomarkers or specific metabolic signatures would provide powerful tools for the management of ALS. The main objective of this study was to investigate the cerebrospinal fluid (CSF) lipido...

Alternative Titles

Full title

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5732162

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5732162

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-017-17389-9

How to access this item